Pivkova Veljanovska, Aleksandra
Preferred name
Pivkova Veljanovska, Aleksandra
Official Name
Pivkova Veljanovska, Aleksandra
Main Affiliation
Email
aleksandra.pv@medf.ukim.edu.mk
aleksandrapivkova@yahoo.com
139 results
Now showing 1 - 10 of 139
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, AML-327: Plasmacytoid Dendritic Cell Proliferation Associated with Acute Myeloid Leukemia: A Case Report(Elsevier BV, 2021-09); ;Ridova, Nevenka ;Stojanovska, Simona ;Trajkova, Sanja - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Treatment of Severe Autoimmune Diseases with Autologous Hematopoietic Stem Cell Transplantation(Македонско лекарско друштво = Macedonian medical association, 2017-01-01); ;Karadzova-Stojanoska, Anzelika; ; Cadievski, Lazar<jats:title>Abstract</jats:title> <jats:p><jats:bold>Introduction.</jats:bold> Autoimmune diseases are a family of more than 100 heterogeneous conditions that affect 5 to 8% of the world’s population. The etiology is still un-known but the disregulation of the regulatory T-lymphocytes play a central role inthe autoimmunity and the success of the long-term remission. Although conventional immunosuppression and new biological agents can provide disease control in severely affected patients, such treatments are rarely curative and alternative strategies are needed. Indeed, severe forms of systemic autoimmune diseases, such as multiple sclerosis (MS), systemic sclerosis (SSc), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA), hematologic immune cytopenia (HIC) and Crohn’s disease are difficult to be treated. High-dose immunosuppressive therapy followed by autologous stem cells transplantation is reliable option for a successive treatment of this group of patients.</jats:p> <jats:p><jats:bold>Aim.</jats:bold> To determine the safety of the procedure of autologous stem cell transplantation in patients with autoimmune diseases and concomitant malignant hematological disorders.</jats:p> <jats:p><jats:bold>Methods.</jats:bold> During a period of 15 years (from September 2000 to September 2015) at the University Clinic of Hematology in Skopje we have treated 6 patients with autoimmune disease and concomitant hematological neoplasm. None of the patients was treated for primary autoimmune diseases. Two men and 4 women, with median age of 47 years were treated. Sjogren syndrome and multiple myeloma were found in 2 patients, polyartheritis nodosa and multiple myeloma in 1 patient, rheumatoid arthritis and acute myeloblastic leukemia in 1, systemic lupus erythematosus and non-Hodgkin lymphoma in 1; severe psoriasis and acute myeloblastic leukemia in 1 patient.</jats:p> <jats:p><jats:bold>Results.</jats:bold> All treated patients are alive after trans-planted procedure, with transplant related mortality day +100: 0.</jats:p> <jats:p><jats:bold>Conclusion.</jats:bold> Autologous stem cell transplantation is safe and recommended option for treatment ofpatients with autoimmune disease and hematologic neoplasm.</jats:p> - Some of the metrics are blocked by yourconsent settings
Item type:Publication, P062 Results of RCHOP6 or RCHOP8 study in the treatment of patients with diffuse large B-cell lymphoma – single institution study(Elsevier BV, 2007-09); ;Stojanovic, A.; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The Vertical Soft Tissue Thickness and Subcrestal Implant Placement as Factors for Peri-implant Crestal bone Stability(Scientific Foundation SPIROSKI, 2021-11-03) ;Veljanovski, Darko ;Atanasovska-Stojanovska, Aneta; ;Mijiritsky, EitanBollen, Curd<jats:p>Aim The aim of this prospective study was to determine the influence of vertical soft tissue thickness on bone level changes in platform-switched implants placed eqicrestally or subcrestally and restored with screw-retained or cement-retained restorations. Methods Platform-switched bone-level implants were placed in a single stage manner in the posterior mandibular region. Implant sites were divided into thick (control) and thin (test) vertical soft tissue groups. The implants in the control group were placed equicrestally. The implant sites from the control group were randomly allocated to receive equicrestally or subcrestally placed implants. Bone remodeling/loss was radiographically measured at baseline, three months postoperatively and six months after delivery of final prosthetic restoration. Results The mean crestal bone loss values three months postoperatively and six months post prosthetic restoration were higher in sites with thin versus sites with thick gingiva. In implant sites with thin gingiva, subcrestally placed implants presented less bone loss than eqicrestally placed implants. Conclusion Platform switched implants are prone to more bone loss when they are placed in sites with thin soft tissue, regardless of the type of final restoration (screw-retained or cement-retained). Subcrestal placement of platform-switched implants can prevent crestal bone loss in sites with vertical soft tissue thickness < 3 mm. </jats:p> - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Poster: AML-327: Plasmacytoid Dendritic Cell Proliferation Associated with Acute Myeloid Leukemia: A Case Report(Elsevier BV, 2021-09); ;Ridova, Nevenka ;Stojanovska, Simona; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Прогностичко одредување на исходот од лекување со автологна трансплантација на матични хематопоетски клетки(SHMSHM - AAMD, 2012); ; ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Primary Myeloid Sarcoma of the Ileum and Mesentery Causing Small Bowel Obstruction: Case Report and Literature Review(Vilnius University Press, 2020-06-10); ; ; <jats:p>Myeloid sarcoma (extramedullary myeloblastoma, granulocytic sarcoma, chloroma) is an extramedullary isolated malignant tumor of myeloblasts and immature myelocytes. It can occur anywhere in the body as a solitary tumor or can be accompanied with acute myeloid leukemia. We are presenting a case of a young male patient that presented with sings of a small bowel obstruction and a palpable tumor mass in the abdomen. After uneventful postoperative period, the immunohistochemistry analysis reported an extramedullary myeloid sarcoma since a normal bone marrow biopsy was revealed.</jats:p> - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Antifungal Prophylaxis In Hematopoietic Stem Cell Transplant Recipients(Scientific Foundation SPIROSKI, 2008-09-01); ; ; ;Cevreska, Lidija - Some of the metrics are blocked by yourconsent settings
Item type:Publication, IMPACT OF INITIAL RENAL INVOLVEMENT AND BENCE JONES PROTEINS IN THE URINE ON OVERALL SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA(Macedonian Association of Anatomists, 2022); ; ; ; Ridova, Nevenka - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Antimycotic prophylaxis in stem cell recipients – single center expirience(Elsevier, 2007-09); ;Cevreska Lidija; ; Ivanovski Martin
